Skip to main content
. 2022 May 5;80(1):95–109. doi: 10.1097/FJC.0000000000001271

FIGURE 6.

FIGURE 6.

ELAVL2 regulated PASMCs migration and proliferation negatively. (A), (B), Immunoblotting analysis of ELAVL2 expression in PASMCs transfected with an ELAVL2-overexpressing plasmid or a control plasmid (n =3). (C), (D), Cell migration was determined by transwell assays at 24 hours (n = 3) (×100). (E), (F), EdU incorporation experiments (n = 3) were used to evaluate cell viability (×200). (G), (H), Immunoblotting analysis of ELAVL2 and PCNA expression in PASMCs of each treatment group (n = 3). OE means overexpression of ELAVL2.